
Launch
Ex-OpenAI Science Leader Launches Warp Sciences with $215 Million to Advance AI-Powered Drug Discovery
Kevin Weil, former head of OpenAI’s science initiatives, launched Warp Sciences, an AI startup that aims to accelerate drug discovery by combining AI, robotics, and laboratory experimentation. The company has raised $215 million in Series A funding at a reported post-money valuation of $865 million.